Probity Medical Research   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Waterloo ON Canada (1992)

Organization Overview

First Clinical Trial
2004
NCT00244842
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Probity Medical Research Inc

Active Ingredients

Drugs in Phase 4 Trials (1)

acetaminophen (tylenol) (1 trial)

Drugs in Phase 3 Trials (3)

dimethyl fumarate (tecfidera) (1 trial)

fumarate (1 trial)

voclosporin (Lupkynis) (2 trials)

Drugs in Phase 2 Trials (2)

msb0010841 (1 trial)

secukinumab (cosentyx) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthralgia (Phase 4)

Arthritis (Phase 4)

Psoriasis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 6